EUVIMEDEUVIMED entdecken
Open Access

Spectrofluorimetric Determination of Silodosin Using NBD‐Cl Reagent: Applications to Capsules and Content Uniformity Testing

Ahmed A Abu-Hassan iD

Luminescence · 2026-07 · 41 (7)

DOI: 10.1002/bio.70564 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Luminescence, online erschienen am 02.07.2026. Verfasst von Ahmed A Abu-Hassan. Beteiligte Einrichtung: Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Al-Azhar University, Assiut Branch, Assiut, Egypt. Hauptthemen laut MEDLINE: Indoles, 4-Chloro-7-nitrobenzofurazan, Fluorescent Dyes. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Silodosin (SDN) works by specifically blocking alpha‐1 adrenergic receptors, with a strong preference for the α1A type and clinically approved for alleviating the symptoms associated with benign prostatic hyperplasia in adult patients. The medication is precisely quantified using a novel, affordable spectrofluorimetric strategy in this paper. The strategy uses a fluorogenic reagent (4‐chloro‐7‐nitrobenzofurazan, NBD‐Cl) to create a fluorescent compound called “SDN‐NBD” when it reacts with SDN. Optimal fluorescence emission was recorded at 534.7 nm (excitation: 473.4 nm) after systematic refinement of reaction variables, including pH, temperature, and NBD‐Cl concentration. The approach exhibited remarkable linearity throughout a spectrum of 40–750 ng/mL ( R 2 > 0.999), with a detection limit of 12.8 ng/mL and a quantitation limit of 38.8 ng/mL. Rigorous validation under International Council for Harmonisation (ICH) guidelines confirmed high accuracy (recovery: 98.92–101.67%) and precision (RSD < 2%). The technique was successfully applied to quantify SDN in pharmaceutical capsules, achieving consistent content uniformity (AV = 5.45). This approach is robust and avoiding costly instrumentation and chromatographic experiments. Its simplicity, reproducibility, and regulatory compliance make it promising for pharmacokinetic research, quality control, and clinical laboratories that need accurate SDN analysis in complicated matrices.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Indoles4-Chloro-7-nitrobenzofurazanFluorescent DyesSpectrometry, FluorescenceCapsulesHydrogen-Ion ConcentrationTemperature

Stichwörter der Autor:innen

NBD‐Clcontent uniformityderivatizationmethod validationpharmaceutical analysisspectrofluorimetry

Substanzen

silodosinIndolesCapsules4-Chloro-7-nitrobenzofurazanFluorescent Dyes7-nitrobenzo-2-oxa-1,3-diazole chloride

Autor:innen und Institutionen

  • Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Al-Azhar University, Assiut Branch, Assiut, Egypt.

ORCID-Profile: Ahmed A Abu-Hassan

Zitieren

APA

Abu-Hassan, A. A. (2026). Spectrofluorimetric Determination of Silodosin Using NBD‐Cl Reagent: Applications to Capsules and Content Uniformity Testing. Luminescence, 41(7). https://doi.org/10.1002/bio.70564

Vancouver

Abu-Hassan AA. Spectrofluorimetric Determination of Silodosin Using NBD‐Cl Reagent: Applications to Capsules and Content Uniformity Testing. Luminescence. 2026;41(7). doi:10.1002/bio.70564

BibTeX
@article{AbuHassan2026,
  author = {Abu-Hassan, Ahmed A},
  title = {Spectrofluorimetric Determination of Silodosin Using NBD‐Cl Reagent: Applications to Capsules and Content Uniformity Testing},
  journal = {Luminescence},
  year = {2026},
  volume = {41},
  number = {7},
  doi = {10.1002/bio.70564}
}
Kostenlos starten →